Patent Number: 7,632,649

Title: Sp1 as a marker in diagnosis and prognosis of non-alcoholic steatohepatitis (NASH) and target in drug screening for NASH

Abstract: Phosphorylated Sp1 can be used as a marker for in vitro diagnosis of non-alcoholic steatohepatitis (NASH) as well as a therapeutical target of said condition.

Inventors: de la Paz; Jose Maria Mato (Cizur Menor, ES)

Assignee: One Way Liver Genomics, S.L.

International Classification: G01N 33/53 (20060101)

Expiration Date: 2/15/02018